Trial intelligence / Profile preview

5% Dextrose Nerve Hydrodissection in Carpal Tunnel Syndrome

NCT07524933Active, not recruiting

Sponsor
Antalya Training and Research Hospital
Start
Jan 2026
Primary completion
Jul 2026
Countries
1
01

Overview

Randomised trial of dextrose in carpal tunnel syndrome (CTS) (3 arms), sponsored by Antalya Training and Research Hospital. Primary endpoint: Visual Analog Scale at 8 months. Started Jan 2026; status: active, not recruiting.

02

Drugs

dextrose
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT07524933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07524933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call